Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

2011 Surveillance Slides

This webpage is archived for historical purposes and is no longer being maintained or updated.

Surveillance Slides Previous Slide Next Slide Last Slide
Slide 19: Primary Anti-TB Drug Resistance, United States, 1993-2011.

Slide 19. Primary Anti-TB Drug Resistance, United States, 1993–2011. Primary drug resistance is shown for the past 19 years. The graph starts in 1993, the year in which the individual TB case reports submitted to the national surveillance system began collecting information on initial susceptibility test results for patients with culture-positive TB. Data were available for more than 85% of culture-positive cases for each year. Primary resis­tance was calculated by using data from persons with no reported prior TB episode. Resistance to at least isoniazid remained between 7.0% and 8.6% between 1993 and 2010, however in 2011, this increased to 9.2%. Resistance to at least isoniazid and rifampin, known as multidrug-resistant TB (MDR TB), decreased from 2.5% in 1993 to 1.1% in 1997, and remained at approximately 1.0 % until 2009 and 2010 when it increased to 1.1% and 1.2%, respec­tively. In 2011, it increased again to 1.3%.

Back to 2011 Surveillance Slides Main Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO